ABSIAbsci Corp

Nasdaq absci.com


$ 3.49 $ -0.52 (-12.94 %)    

Monday, 09-Sep-2024 15:59:54 EDT
QQQ $ 455.25 $ 5.77 (1.29 %)
DIA $ 409.08 $ 4.58 (1.13 %)
SPY $ 546.60 $ 6.05 (1.12 %)
TLT $ 99.96 $ 0.43 (0.43 %)
GLD $ 231.58 $ 0.97 (0.42 %)
$ 3.5
$ 4.03
$ 3.49 x 200
-- x --
$ 3.49 - $ 4.09
$ 1.11 - $ 6.72
1,990,723
na
397.45M
$ 2.22
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2024 06-30-2024 10-Q
2 05-14-2024 03-31-2024 10-Q
3 03-21-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
6 05-15-2023 03-31-2023 10-Q
7 03-30-2023 12-31-2022 10-K
8 11-09-2022 09-30-2022 10-Q
9 08-11-2022 06-30-2022 10-Q
10 05-11-2022 03-31-2022 10-Q
11 03-22-2022 12-31-2021 10-K
12 11-09-2021 09-30-2021 10-Q
13 09-07-2021 06-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-absci-maintains-7-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Absci (NASDAQ:ABSI) with a Buy and maintains $7 price target.

 absci-q2-2024-gaap-eps-022-misses-020-estimate-sales-127m-miss-191m-estimate

Absci (NASDAQ:ABSI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.20) by 10...

 absci-collaborates-with-memorial-sloan-kettering-cancer-center-to-discover-novel-therapeutics-using-generative-ai

Today, Absci Corporation (NASDAQ:ABSI), a data-first generative AI drug creation company, announced a collaboration with Memori...

 keybanc-maintains-overweight-on-absci-lowers-price-target-to-6

Keybanc analyst Scott Schoenhaus maintains Absci (NASDAQ:ABSI) with a Overweight and lowers the price target from $8 to $6.

 morgan-stanley-initiates-coverage-on-absci-with-overweight-rating-announces-price-target-of-7

Morgan Stanley analyst Vikram Purohit initiates coverage on Absci (NASDAQ:ABSI) with a Overweight rating and announces Price...

 cathie-woods-ark-invest-sells-coinbase-shares-as-bitcoin-drops-below-key-62k-level

On Monday, Cathie Wood-led Ark Invest made some significant trades, with Coinbase Global Inc. (NASDAQ:COIN) taking the spotligh...

 cathie-wood-led-ark-invest-cuts-robinhood-holdings-amid-bitcoin-dip-keeps-selling-moderna-stock--buys-palantir-and-amd-shares

On Wednesday, Ark Invest, led by the influential investor Cathie Wood, executed notable trades involving Robinhood Markets Inc ...

 hc-wainwright--co-reiterates-buy-on-absci-maintains-7-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Absci (NASDAQ:ABSI) with a Buy and maintains $7 price target.

 absci-q1-2024-gaap-eps-022-misses-021-estimate-sales-898000k-miss-2419m-estimate

Absci (NASDAQ:ABSI) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.21) by 4....

 blackberry-nurix-therapeutics-tesla-and-other-big-stocks-moving-higher-on-tuesday

U.S. stocks were lower, with the Dow Jones index falling over 200 points on Tuesday. Shares of BlackBerry Limited (NYSE: BB) ...

 truist-securities-maintains-buy-on-absci-maintains-9-price-target

Truist Securities analyst Robyn Karnauskas maintains Absci (NASDAQ:ABSI) with a Buy and maintains $9 price target.

 hc-wainwright--co-reiterates-buy-on-absci-maintains-7-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Absci (NASDAQ:ABSI) with a Buy and maintains $7 price target.

 absci-q4-earnings-insights
Absci: Q4 Earnings Insights
03/21/2024 14:55:06

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION